At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 73 enrolled
Drug / intervention
Ardian Symplicity™ Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Renal Denervation in Patients With Refractory Hypertension
In Brief
A Phase 1 clinical trial evaluating Ardian Symplicity™ Catheter for Hypertension. Completed, enrolled 73 participants across 3 sites in 2 countries.
Detailed Summary
To investigate the clinical utility of renal denervation in the treatment of refractory hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesAustralia, Poland
Collaborators--
Timeline
Phase 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2007
First PostedJun 2007
Primary CompletionMay 2013
TodayJul 2026
First PostedJun 7, 2007
Enrollment StartJun 1, 2007
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 19.1 years ago
Interventions
Ardian Symplicity™ Catheterdevice
Renal denervation using the Symplicity Catheter